Jockers-Scherübl MC - Search Results

1

Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.

Höpfner M, Sutter AP, Beck NI, Barthel B, Maaser K, Jockers-Scherübl MC, Zeitz M, Scherübl H. Höpfner M, et al. Int J Cancer. 2002 Sep 20;101(3):210-6. doi: 10.1002/ijc.10553. Int J Cancer. 2002. PMID: 12209970

2

Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.

Lemmer K, Ahnert-Hilger G, Höpfner M, Hoegerle S, Faiss S, Grabowski P, Jockers-Scherübl M, Riecken EO, Zeitz M, Scherübl H. Lemmer K, et al. Life Sci. 2002 Jun 28;71(6):667-78. doi: 10.1016/s0024-3205(02)01703-4. Life Sci. 2002. PMID: 12072155

3

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.

Jockers-Scherübl MC, Bauer A, Godemann F, Reischies FM, Selig F, Schlattmann P. Jockers-Scherübl MC, et al. Int Clin Psychopharmacol. 2005 Jan;20(1):27-31. doi: 10.1097/00004850-200501000-00006. Int Clin Psychopharmacol. 2005. PMID: 15602113 Clinical Trial.

4

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

Jockers-Scherübl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gómez-Carrillo de Castro A, Kühl KP. Jockers-Scherübl MC, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1054-63. doi: 10.1016/j.pnpbp.2007.03.006. Epub 2007 Mar 16. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17482741

5

Nerve growth factor in serum is a marker of the stage of alcohol disease.

Jockers-Scherübl MC, Bauer A, Kuhn S, Reischies F, Danker-Hopfe H, Schmidt LG, Rentzsch J, Hellweg R. Jockers-Scherübl MC, et al. Neurosci Lett. 2007 May 23;419(1):78-82. doi: 10.1016/j.neulet.2007.03.051. Epub 2007 Mar 30. Neurosci Lett. 2007. PMID: 17434673

6

Neurotrophins: from pathophysiology to treatment in Alzheimer's disease.

Schulte-Herbrüggen O, Jockers-Scherübl MC, Hellweg R. Schulte-Herbrüggen O, et al. Curr Alzheimer Res. 2008 Feb;5(1):38-44. doi: 10.2174/156720508783884620. Curr Alzheimer Res. 2008. PMID: 18288930 Review.

7

Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder.

Jockers-Scherübl MC, Zubraegel D, Baer T, Linden M, Danker-Hopfe H, Schulte-Herbrüggen O, Neu P, Hellweg R. Jockers-Scherübl MC, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):200-4. doi: 10.1016/j.pnpbp.2006.09.006. Epub 2006 Oct 20. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17055636

8

Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.

Jockers-Scherübl M, Godemann F, Pietzcker A. Jockers-Scherübl M, et al. J Clin Psychiatry. 2001 Jul;62(7):573. doi: 10.4088/jcp.v62n07c13. J Clin Psychiatry. 2001. PMID: 11488373 Clinical Trial. No abstract available.

9

Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.

Jockers-Scherübl MC, Danker-Hopfe H, Mahlberg R, Selig F, Rentzsch J, Schürer F, Lang UE, Hellweg R. Jockers-Scherübl MC, et al. Neurosci Lett. 2004 Nov 16;371(1):79-83. doi: 10.1016/j.neulet.2004.08.045. Neurosci Lett. 2004. PMID: 15500971

10

Early orbitofrontal hyperactivation in obsessive-compulsive disorder.

Lagemann T, Rentzsch J, Montag C, Gallinat J, Jockers-Scherübl M, Winter C, Reischies FM. Lagemann T, et al. Psychiatry Res. 2012 Jun 30;202(3):257-63. doi: 10.1016/j.pscychresns.2011.10.002. Epub 2012 Jul 16. Psychiatry Res. 2012. PMID: 22809741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page